US 8293729
Compounds, pharmaceutical composition and methods relating thereto
granted A61PA61P3/04A61P3/10
Quick answer
US patent 8293729 (Compounds, pharmaceutical composition and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P3/04, A61P3/10, A61P43/00, A61P7/12